RCE 2.86% 51.0¢ recce pharmaceuticals ltd

Ann: Dr Philip Sutton - V.P. of Translational Sciences, page-10

  1. 267 Posts.
    lightbulb Created with Sketch. 278

    Totally disagree lonade….RCE unlike other companies on the ASX (especially speculative companies) has not been in the business of wasting shareholders money and has been proven to spend shareholders money at hand wisely and I’m sure most long term holders would agree!

    James has to be commended for how this company has been run over the years and I for one would not question decision made thus far.

    I believe the appointment of Dr Phillip Sutton is a great sign for the future for Recce the company and @zecs nailed it when he stated in his previous post. “ Someone with the background of Dr Sutton is not climbing on board the bus without very good reason”wink.png

    Some significant things happening in the background and it won’t be a long wait.biggrin.png


 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
51.0¢
Change
-0.015(2.86%)
Mkt cap ! $118.1M
Open High Low Value Volume
52.0¢ 52.0¢ 50.5¢ $40.89K 79.63K

Buyers (Bids)

No. Vol. Price($)
1 677 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
52.5¢ 392 1
View Market Depth
Last trade - 15.59pm 13/09/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.